Search PubMed⌕ Search

Biomedical subjects

J Hermans

Publications and source records attributed to J Hermans.

At least 649 records · Page 36Linked to original sources
PubMedDate not supplied

The performance of logistic discrimination on myocardial infarction data, in comparison with some other discriminant analysis methods.

The Imminent Myocardial Infarction study Rotterdam (IMIR), concerns patients who visit their general practitioners and have complaints suspected to be of cardiac origin. The study aims to develop a protocol for diagnosing myocardial infarction without laboratory assistance. We use the IMIR data, consisting of continuous and binary variables, to compare the diagnostic performance of logistic discrimination with some other discriminant analysis techniques. We discuss which characterizations of mixed data sets may give indications for an appropriate choice from among the alternative methods for discrimination.

Humans↗
PubMedDate not supplied

Multistate modelling of liver transplantation data.

This paper concerns the survival analysis of liver transplant patients when patients with a potentially fatal rejection of the transplanted organ may receive a retransplant. A multistate model, analysing the states 'alive with first graft' and 'alive with second graft' separately, is suggested. Proportional hazards models and logistic regression models are used to evaluate which risk factors related to donor, preservation and recipient, influence the transition intensities. The complete model is used to predict overall survival of a patient and to study the influence of the risk factors on total survival.

Adolescent↗
PubMedDate not supplied

Comparison of factors influencing the prognosis of Japanese, German, and Dutch gastric cancer patients.

As a result of Japanese reports of improved survival of gastric cancer patients after extended lymph node dissection, a study was undertaken to evaluate factors that might influence these results. The influence of staging was evaluated by stratifying 1085 patients of the National Cancer Center of Japan and grouping them according to the three commonly used systems; UICC's old and new TNM systems (fourth edition) and the system of the Japanese Research Society for the study of Gastric Cancer (JRSGC). No survival difference was found between the stages of the three systems, except for stage II, where the new TNM and the JRSGC differed (p < 0.05). In a second analysis, the incidence of the most important prognostic factors for advanced gastric cancer was compared among three institutions: the National Cancer Center Tokyo, Japan (NCC), the University Hospital Erlangen, Germany (UHE) and the University Hospital Maastricht in The Netherlands (UHM). Japanese patients were on average 3 years younger than the German patients and 8 years younger than the Dutch patients, and had a higher proportion of advanced (T4) carcinomas. Male-female distribution, histology, and lymph node invasion were comparable in the three groups. From these data a rather worse prognosis for Japanese advanced gastric cancer patients could be expected. However, the observed 5-year survival rates show a marked advantage for the Japanese patients: 57% (NCC) versus 34% (UHE) and 31% (UHM). The survival difference for stage II patients between the new TNM and the JRSGC staging systems is not sufficient to explain this advantage. This result underlines the importance of the Japanese therapeutic approach.(ABSTRACT TRUNCATED AT 250 WORDS)

Age Factors↗
PubMedDate not supplied

T-cell evaluation in patients with colon cancer: dinitrochlorobenzene skin testing versus plasma levels of sIL-2r and sCD8.

BACKGROUND: Developing reliable methods to test the T-cell system may be important in the treatment of colon cancer patients with 5-fluorouracil/levamisole. In a pilot study we explored whether DNCB (dinitrochlorobenzene) skin testing correlated with plasma levels of soluble interleukin-2 receptor (sIL-2r) and soluble CD8 (sCD8) and, secondly, whether the application of DNCB had any influence on the production of sIL-2r and sCD8. METHODS: In 10 patients with advanced colon cancer and in 10 healthy volunteers, plasma levels of sIL-2r and sCD8 were measured before and 10 days after the application of 2 mg DNCB on the inner side of the forearm. RESULTS: As expected, colon cancer patients showed a depressed immune system compared to healthy volunteers (DNCB skin test: P = .005, sIL2r [medians 700 vs 295, P = .002], sCD8 [medians 158 vs 90, P = .03], M-W test). The plasma levels for sIL-2r and sCD8 were significantly lower in the skin-positive cases (P = .01 and P = .03, M-W test). However, a large overlap in plasma levels could be observed between the two skin categories. DNCB had no influence on the production of sIL-2r and sCD8; median change skin-negative and skin-positive -10 vs +25, P = .14, respectively; 48 vs 0, P = .32 (M-W test). CONCLUSIONS: DNCB skin testing and plasma levels of sIL-2r and sCD8 seem to be equally useful in evaluating the T-cell system and can be used simultaneously.

Adjuvants, Immunologic↗
PubMedDate not supplied

Endometrial carcinoma, results of combined surgery and radiotherapy treatment of 93 patients (1979-1984).

A retrospective analysis was done on 93 cases with clinical stage I and II endometrial carcinoma. All patients in this series were treated by surgery and postoperative radiotherapy. Five-year survival reached 67%. No vaginal or vault recurrences were seen. Grade, stage and depth of myometrial invasion were prognostic parameters for survival, whereas 'age' did not show correlation with survival. Postoperative radiotherapy was performed by two different protocols, one of which appeared to be allied with significantly less late toxicity than the other.

Adenocarcinoma↗